Millstone Evans Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.5K Sell
138
-112
-45% -$31K 0.02% 445
2026
Q1
$73.8K Buy
250
+12
+5% +$3.56K 0.04% 268
2025
Q4
$65K Hold
238
0.04% 285
2025
Q3
$64.3K Sell
238
-62
-21% -$16.9K 0.04% 271
2025
Q2
$82.7K Hold
300
0.06% 229
2025
Q1
$79.6K Hold
300
0.05% 230
2024
Q4
$69.7K Buy
+300
New +$69K 0.05% 233

Other funds holding CME

Millstone Evans Group's CME Position: Q2 2026 in Review

Millstone Evans Group reduced its CME Group (CME) stake by 45% in Q2 2026, selling an estimated $31K and leaving 138 shares worth $30.5K. The position accounts for 0.02% of the portfolio, ranked #445.

Millstone Evans Group first reported a position in CME in Q4 2024 and has held it in 7 quarters since. The position peaked at $82.7K in Q2 2025. 1,380 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Millstone Evans Group held 138 shares of CME Group worth $30.5K as of Q2 2026.
  • Millstone Evans Group sold 112 CME Group shares in Q2 2026, an estimated $31K.
  • CME Group made up 0.02% of Millstone Evans Group's portfolio in Q2 2026, its #445 holding.
  • Millstone Evans Group first reported a position in CME Group in Q4 2024 and has held it in 7 quarters since.
  • Millstone Evans Group's CME Group position peaked at $82.7K in Q2 2025.
  • 1,380 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.